Equity Components [Axis] Common Stock [Member] Additional Paid-in-Capital [Member] Accumulated Deficit Antidilutive Securities [Axis] Outstanding Options [Member] Outstanding Warrants [Member] Convertible Preferred Stock [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Related Party [Axis] Investor [Member] Warrants [Member] Plan Name [Axis] 2015 Long-term Incentive Plan [Member] Award Type [Axis] Stock Options [Member] Award Date [Axis] 2020 [Member] 2021 [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Exclusive License Agreement [Member] Title of Individual [Axis] Dr. Brent Satterfield [Member] Dr. Satterfield [Member] Convertible Preferred Stock [Member] Legal Entity [Axis] Two Companies [Member] Four Individuals [Member] Ten Employees and Two Member of Board of Directors [Member] Three Companies [Member] Professional Services Agreement [Member] 2022 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Common Stock [Member] Revision of Prior Period [Axis] As Previously Reported [Member] Adjustments [Member] Restatement [Axis] As previously Reported [Member] Adjustment [Member] Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Amendment Description Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS: Current assets Cash and cash equivalents Accounts receivable, net Inventory Prepaid expenses Total current assets Property and equipment, net Investment in joint venture Total assets Liabilities and stockholders' equity Current liabilities Accounts payable Accrued expenses Accrued expenses (related party) Deferred revenue Total current liabilities Accrued expenses-long-term (related party) Total liabilities Commitments and contingencies (Note 1) Stockholders' equity Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized; 0 and 25,600 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively Common Stock, $0.001 par value; 100,000,000 shares authorized; 27,991,042 and 17,342,922 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Convertible preferred stock, par value Convertible preferred stock , shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Net revenue Cost of revenue Gross profit Operating expenses Sales and marketing Administrative and general Research and development Depreciation and amortization Total operating expenses Income (loss) from operations Other income (expense) Interest income Interest expense Gain on disposition of assets Gain (loss) on equity method investment in joint venture Total other income (expense) Income (loss) before income taxes Provision for income taxes Net income (loss) Net income (loss) per common share: Basic Diluted Weighted average shares outstanding: Basic Diluted Statement of Cash Flows [Abstract] Cash flows from operating activities Net income (loss) Adjustments to reconcile net income (loss) to cash used in operating activities: Stock-based compensation expense Accretion of notes payable discount Gain on disposition of assets Loss (gain) from equity method investment Changes in assets and liabilities: Accounts and other receivable Prepaid and other assets Inventory Deffered revenue Accounts payable and accrued expenses Net cash used in operating activities Cash flows from investing activities Purchase of property and equipment Investment in joint venture Net cash used in investing activities Cash flows from financing activities Proceeds from sale of common stock Proceeds from sale of preferred stock Proceeds from exercise of options and warrants Payment of offering costs Net cash provided by financing activities Net increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental disclosure of cash flow information Interest paid Income taxes paid Supplemental disclosure of non-cash investing and financing transactions Inventory moved to property, plant and equipment Statement [Table] Statement [Line Items] Beginning balance Beginning balance, shares Public offering, net of offering costs Public offering, net of offering costs, shares Issuance of common stock for warrant exercises Issuance of common stock for warrant exercises, shares Issuance of common stock for option and warrant exercises Issuance of common stock for option and warrant exercises, shares Stock-based compensation expense Stock-based compensation expense, shares Issuance of common stock for services Issuance of common stock for services, shares Conversion of preferred stock to common Conversion of preferred stock to common, shares Issuance of preferred stock Issuance of preferred stock, shares Net Income (loss) Ending balance Ending balance, shares Statement of Stockholders' Equity [Abstract] Public offering costs Accounting Policies [Abstract] Overview and Basis of Presentation Summary of Significant Accounting Policies Accounting Changes and Error Corrections [Abstract] Restatement of Condensed Consolidated Financial Statements (Unaudited) Equity [Abstract] Equity Share-based Payment Arrangement, Disclosure [Abstract] Stock-Based Compensation Related Party Transactions [Abstract] Related Party Transactions Leases [Abstract] Lease Obligations Subsequent Events [Abstract] Subsequent Events Accounts Receivable Equity-Method Investments Inventory Revenue Recognition Earnings (Loss) Per Share Research and Development Recent Accounting Pronouncements Commitments and Contingency Schedule of Restatement of Unaudited Consolidated Financial Statements Schedule of Fair Value of Options Weighted Average Assumptions Schedule of Option Activity Schedule of Warrant Activity Schedule of Unrecognized Stock-based Compensation Schedule of Ongoing Lease Obligation Accounts receivable Doubtful accounts Inventory finished goods Inventory raw materials Potentially dilutive shares Research and development cost Net income per common share for basic and diluted Stockholders' equity Total current assets Total assets Total current liabilities Total liabilities Total stockholders' equity Total liabilities and stockholders' equity Gross profit Total operating expenses Income from operations Total other expense (expense) Income (loss) before income taxes Net income Basic income (loss) per common share Diluted income (loss) per common share Weighted average common shares outstanding basic Weighted average common shares outstanding diluted Net cash used in operating activities Net cash used in investing activities Net cash provided by financing activities Net increase in cash and cash equivalents Schedule of Stock by Class [Table] Class of Stock [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Number of common stock issued Sale of common stock purchase price per shares Issuance of common stock gross proceeds Net proceeds from issuance of common stock Offering costs Number of common stock issued, value Stock issued during period, warrant exercised value Warrants exercisable price per share Number of conversion of shares issued Conversion of preferred stock Conversion of preferred stock, price per shares Number of warrants exercised Number of shares issued for services Value of shares issued for services Proceeds from warrants exercise Proceeds from stock option exercised Number of stock option exercised Purchase price Promissory note Equity ownership percentage Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Aggregate number of common shares reserved Unissued common stock options authorized shares Stock based compensation Intrinsic value of options outstanding Unvested option shares outstanding Intrinsic value of options and warrants exercised Unrecognized stock-based compensation Share-based Payment Arrangement [Abstract] Risk free interest rate Expected life (years) Expected volatility Expected dividend yield Stock price Options Outstanding, Beginning Options Outstanding, Granted Options Outstanding, Expired Options Outstanding, Forfeited/Cancelled Options Outstanding, Exercised Options Outstanding, Ending Weighted Average Exercise Price Outstanding, Beginning Weighted Average Exercise Price Granted Weighted Average Exercise Price Expired Weighted Average Exercise Price Forfeited/Cancelled Weighted Average Exercise Price Exercised Weighted Average Exercise Price Outstanding, Ending Weighted Average Fair Value Outstanding, Beginning Weighted Average Fair Value Granted Weighted Average Fair Value Expired Weighted Average Fair Value Forfeited/Cancelled Weighted Average Fair Value Exercised Weighted Average Fair Value Outstanding, Ending Weighted-average Remaining Contractual Life (years) Outstanding, Beginning Weighted-average Remaining Contractual Life (years) Granted Weighted-average Remaining Contractual Life (years) Forfeited/Cancelled Weighted-average Remaining Contractual Life (years) Exercised Weighted-average Remaining Contractual Life (years) Outstanding, Ending Number of Warrants Outstanding, Beginning Number of Warrants Outstanding, Granted Number of Warrants Outstanding, Expired Number of Warrants Outstanding, Forfeited/Cancelled Number of Warrants Outstanding, Exercised Number of Warrants Outstanding, Ending Weighted Average Exercise Price, Beginning Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Expired Weighted Average Exercise Price, Forfeited/Cancelled Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Ending Weighted Average Fair Value, Beginning Weighted Average Fair Value, Granted Weighted Average Fair Value, Expired Weighted Average Fair Value, Forfeited/Cancelled Weighted Average Fair Value, Exercised Weighted Average Fair Value, Ending Weighted-average Remaining Contractual Life (Years), Beginning Weighted-average Remaining Contractual Life (Years), Granted Weighted-average Remaining Contractual Life (Years), Exercised Weighted-average Remaining Contractual Life (Years), Ending Total Accrued royalties Increase in Royalties Payable, per month Due to related party Lease term Area of land Payments for rent Lease expiration date Rent expenses 2020 (remainder) 2021 2022 2023 2024 Total lease payments Stock issued for exercise of warrants. Stock issued for exercise of warrants, shares. Stock issued during pPeriod value preferred stock. Stock issued during period shares preferred stock. Joint Venture Agreement [Member] Series A Convertible Preferred Stock [Member] Two Indivuduals [Member] Professional Services Agreements [Member] Three Companies [Member] Two Companies [Member] 2015 Long-term Incentive Plan [Member] Stock Options [Member] Adjusted to Issuance of Equity [Member] Sales and Marketing [Member] Repurchasing Of Market Licensing Agreement [Member] Four Companies [Member] One Company [Member] 2020 [Member] 2021 [Member] Dr. Satterfield [Member] Exclusive License Agreement [Member] Dr. Brent Satterfield [Member] Convertible Preferred Stock [Member] Proceeds from exercise of options and warrants. Inventory moved to property, plant and equipment. Issuance of Common Stock for option and warrant exercises. Issuance of Common Stock for option and warrant exercises, shares Outstanding Options [Member] Outstanding Warrants [Member] Four Individuals [Member] Ten Employees and Two Member of Board of Directors [Member] Professional Services Agreement [Member] 2022 [Member] Common Stock [Member] Public offering costs. Share-based Compensation Arrangement by Share-based Payment Award, Options and Warrants, Exercises in Period, Intrinsic Value. Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value. Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted-average Remaining Contractual Life (years) Options granted. Weighted-average Remaining Contractual Life (years) Options Forfeited options. Weighted-average Remaining Contractual Life (years) Options Exercised. Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option plan. Share-based compensation arrangements by share-based payment award, non-options, grants in period, weighted average exercise price. Weighted average price at which grantees could have acquired the underlying shares with respect to non-options of the plan that expired. Weighted average price at which grantees could have acquired the underlying shares with respect to non-options that were terminated. Share-based compensation arrangements by share-based payment award, non-options, exercise in period, weighted average exercise price Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option plan. Share-based compensation arrangement by share-based payment award, non-option, weighted average exercise price Share-based compensation arrangement by share-based payment award, non-option, granted in period, weighted average exercise price. Share-based compensation arrangement by share-based payment award, non-option, expirations, weighted average exercise price. Share-based compensation arrangement by share-based payment award, non-option, forfeitures, weighted average exercise price. Share-based compensation arrangement by share-based payment award, non-option, exercise in period, weighted average exercise price. Share-based compensation arrangement by share-based payment award, non-options, outstanding, weighted average remaining contractual term. Share-based compensation arrangement by share-based payment award, non-options, granted in period, weighted average remaining contractual term. Share-based compensation arrangement by share-based payment award, non-options, exercise in period, weighted average remaining contractual term. Share-based compensation arrangement by share-based payment award, non-options, outstanding, weighted average remaining contractual term. Net proceeds from issuance of common stock. Stock issued during period, value warrant options exercised. Conversion of preferred stock, price per shares. Purchase price. ConvertiblePreferredStocksMember CommonStockOneMember Interest Expense, Other Gain (Loss) on Sale of Equity Investments Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Inventories Increase (Decrease) in Deferred Income Taxes Payments to Acquire Property, Plant, and Equipment Payments to Acquire Interest in Joint Venture Payments of Stock Issuance Costs Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Shares, Outstanding Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture Inventory, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonOutstandingWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsWeightedAverageGrantDateFairValue Lessee, Operating Lease, Liability, to be Paid